Pediatric Vaccine Global Market Report 2023 – By V Pediatric Vaccine Global Market Report 2023 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2023-2032 ...(expand)

Pediatric vaccines refer to medications that are typically given to children as a form of protection against serious, frequently fatal diseases. They get the children’s body ready to battle the disease more quickly and successfully by boosting its natural defences. For further insights on the pediatric vaccine market, request a sample here

The pediatric vaccine market growth is aided by rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below. However, some pediatric vaccine market restraints include vaccine refusal by parents for their children. For further insights on the pediatric vaccine market, request a sample here

The pediatric vaccine market is expected to reach $65.01 billion in 2027 at a rate of 11.1%. For further insights on the pediatric vaccine market, request a sample here

The global pediatric vaccine market is segmented as
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies
3) By Application: Infectious Disease, Allergy, Cancer
For further insights on the pediatric vaccine market, request a sample here

North America was the largest region in the pediatric vaccine market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Key competitors in the pediatric vaccine market are, GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., Zydus Cadila, BIO-MED, Squibb, Novartis, Abbott Laboratries, Eli Lillyand Company, F. Hoffmann- La Roche Ltd., Novo Nordisk A/S, VF Corporation, Sinovac Biotech Ltd., Bristol- Myers, Sun Pharmaceutical Industries Ltd, Sellas and Takeda Pharmaceutical Company Limited, Daiichi Sankyo, Bristol- Myers, Sinovac Biotec Ltd. For further insights on the pediatric vaccine market, request a sample here.

Major trends influencing the pediatric vaccine market include growing demand for novel vaccines to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest for pediatric vaccine manufacturers and developers for the innovation of vaccine design and manufacturing technologies. For further insights on the pediatric vaccine market, request a sample here.

For detailed insights on the major opportunities and strategies in the pediatric vaccine market, request a sample here.

For detailed insights on pediatric vaccine market's relation to the overall economy and other similar markets, request a sample here.

For detailed insights on the mergers and acquisitions in the pediatric vaccine industry, request a sample here.

For detailed insights on the key dynamics influencing the pediatric vaccine market growth and SWOT analysis of the pediatric vaccine industry, request a sample here.